COHERUS BIOSCIENCES INC (CHRS) Stock Institutional Trading Activity


COHERUS BIOSCIENCES INC (CHRS) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC and Disciplined Growth Investors. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCBuy113,800137,900$195,818
Q3 2025Renaissance Technologies LLCSell-498,82524,100$39,524
Q2 2025Renaissance Technologies LLCBuy12,297522,925$382,415
Q1 2025Renaissance Technologies LLCBuy78,560510,628$412,077
Q4 2024Disciplined Growth InvestorsSell-199,562566,746$782,109
Q3 2024Renaissance Technologies LLCBuy37,240432,068$449,351
Q3 2024Disciplined Growth InvestorsSell-490,781766,308$796,960
Q2 2024Renaissance Technologies LLCBuy242,500394,828$683,052
Q2 2024Disciplined Growth InvestorsBuy1,1521,257,089$2,174,764
Q1 2024Renaissance Technologies LLCBuy99,528152,328$364
Q1 2024Disciplined Growth InvestorsBuy89,2101,255,937$3,001,689
Q4 2023Disciplined Growth InvestorsSell-16,8991,166,727$3,885,201
Q3 2023Disciplined Growth InvestorsBuy3,9411,183,626$4,426,761
Q2 2023Disciplined Growth InvestorsBuy14,1731,179,685$5,037,255
Q1 2023Disciplined Growth InvestorsBuy22,0921,165,512$7,972,102
Q4 2022Disciplined Growth InvestorsBuy11,3241,143,420$9,055,886
Q3 2022Renaissance Technologies LLCSell-152,70052,800$507
Q3 2022Disciplined Growth InvestorsBuy886,0751,132,096$10,879
Q2 2022Renaissance Technologies LLCBuy41,400205,500$1,488
Q2 2022Disciplined Growth InvestorsBuy1,100246,021$1,781
Q1 2022Renaissance Technologies LLCBuy108,300164,100$2,119
Q1 2022Disciplined Growth InvestorsBuy8,855244,921$3,162
Q4 2021Renaissance Technologies LLCSell-174,90055,800$891
Q4 2021Disciplined Growth InvestorsSell-218,358236,066$3,768
Q2 2021Disciplined Growth InvestorsBuy45,581454,424$6,285
Q1 2021Renaissance Technologies LLCSell-30,500230,700$3,371
Q1 2021Disciplined Growth InvestorsSell-49,600408,843$5,973
Q4 2020Renaissance Technologies LLCBuy179,300261,200$4,540
Q4 2020Disciplined Growth InvestorsSell-13,771458,443$7,968
Q3 2020Renaissance Technologies LLCSell-324,20081,900$1,502

Frequently asked questions about CHRS activity

  • Which institutional owners are buying CHRS?

    Institutional owners buying CHRS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in CHRS activity?

    "Buy" means an investor increased their reported position in CHRS compared to the prior reporting period. This reflects growing exposure to COHERUS BIOSCIENCES INC (CHRS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in CHRS increasing?

    Institutional interest in CHRS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.